| Date |
Report No. |
Title |
| Date Oct. 11, 2000 |
Report No. GAO-01-92T |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. Wednesday, October 11, 2000 Testimony
Before the Committee on Government Reform, House of Representatives ANTHRAX VACCINE Preliminary Results of GAO’s Survey of Guard/Reserve Pilots and Aircrew Members
Statement of Kwai-Cheung Chan, Director Applied Research and Methods GAO-01-92T Mr. Chairman and Members ... |
| Date April 14, 2000 |
Report No. T-NSIAD-00-140 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 1:00 p.m., CDT Friday, April 14, 2000 Testimony
Before the Subcommittee on Personnel, Committee on Armed Services, U.S. Senate CONTRACT MANAGEMENT DOD’s Anthrax Vaccine Manufacturer Will Continue to Need Financial Assistance
Statement of David E. Cooper, Associate Director Defense Acquisition Issues National Security... |
| Date Nov. 4, 1999 |
Report No. NSIAD-00-54R |
Title
United States General Accounting Washington, DC 20548 Office National Security and International Affairs Division B-284044 November 4, 1999 The Honorable Steve Buyer Chairman, Subcommittee on Military Personnel Committee on Armed Services House of Representatives Subject: Summary Vaccine of GAO’s Findinas on the Safetv and Efficacv of the Anthrax Dear Mr. Chairman: Concerns have been raised abou... |
| Date Oct. 22, 1999 |
Report No. NSIAD-00-36 |
Title
United States General Accounting Office GAO
October 1999 Report to the Chairman and Ranking Minority Member, Committee on Veterans’ Affairs, U.S. Senate MEDICAL READINESS DOD Faces Challenges in Implementing Its Anthrax Vaccine Immunization Program GAO/NSIAD-00-36 Contents Letter Appendixes
Appendix I: Appendix II: Scope and Methodology Packaging and Shipping Protocol 3 38 41 43 48 53 54 Appendi... |
| Date Oct. 20, 1999 |
Report No. T-NSIAD-00-49 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m., EDT Wednesday, October 20, 1999 Testimony
Before the Subcommittees on Military Procurement and on Military Research and Development, Committee on Armed Services, House of Representatives CHEMICAL AND BIOLOGICAL DEFENSE Observations on Actions Taken to Protect Military Forces
Statement of Norman J. Rabkin, D... |
| Date Oct. 12, 1999 |
Report No. T-NSIAD-00-48 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 1:00 p.m., EDT Tuesday, October 12, 1999 Testimony
Before the Committee on Government Reform, House of Representatives ANTHRAX VACCINE Safety and Efficacy Issues
Statement of Kwai-Cheung Chan, Director, Special Studies and Evaluations, National Security and International Affairs Division GAO/T-NSIAD-00-48 Mr. Chairman ... |
| Date July 21, 1999 |
Report No. T-NSIAD-99-226 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00, a.m., EDT Wednesday, July 21, 1999 Testimony
Before the Subcommittee on National Security, Veterans’ Affairs, and International Relations, Committee on Government Reform, House of Representatives MEDICAL READINESS Issues Concerning the Anthrax Vaccine
Statement of Kwai-Cheung Chan, Director Special Studies and... |
| Date June 30, 1999 |
Report No. T-NSIAD-99-214 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m., EDT Wednesday, June 30, 1999 Testimony
Before the Subcommittee on National Security, Veterans Affairs, and International Relations, Committee on Government Reform, House of Representatives CONTRACT MANAGEMENT Observations on DOD’s Financial Relationship With the Anthrax Vaccine Manufacturer
Statement of L... |
| Date April 29, 1999 |
Report No. T-NSIAD-99-148 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m., EST Thursday, April 29, 1999 Testimony
Before the Subcommittee on National Security, Veterans’ Affairs, and International Relations, Committee on Government Reform, House of Representatives MEDICAL READINESS Safety and Efficacy of the Anthrax Vaccine
Statement of Kwai-Cheung Chan, Director, Special Studie... |
